SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-066893
Filing Date
2023-08-14
Accepted
2023-08-14 15:10:59
Documents
86
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_allarityther.htm   iXBRL 10-Q 1192284
2 FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEME f10q0623ex10-1_allarityther.htm EX-10.1 13852
3 CERTIFICATION f10q0623ex31-1_allarityther.htm EX-31.1 8037
4 CERTIFICATION f10q0623ex31-2_allarityther.htm EX-31.2 8113
5 CERTIFICATION f10q0623ex32-1_allarityther.htm EX-32.1 3903
6 CERTIFICATION f10q0623ex32-2_allarityther.htm EX-32.2 3741
  Complete submission text file 0001213900-23-066893.txt   6996597

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE allr-20230630.xsd EX-101.SCH 79188
8 XBRL CALCULATION FILE allr-20230630_cal.xml EX-101.CAL 39665
9 XBRL DEFINITION FILE allr-20230630_def.xml EX-101.DEF 356950
10 XBRL LABEL FILE allr-20230630_lab.xml EX-101.LAB 678392
11 XBRL PRESENTATION FILE allr-20230630_pre.xml EX-101.PRE 376931
80 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_allarityther_htm.xml XML 741725
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41160 | Film No.: 231169027
SIC: 2834 Pharmaceutical Preparations